Infinity Pharmaceuticals Inc Asset Turnover Ratio (INFI), as of second quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Infinity Pharmaceuticals Inc   (NASDAQ: INFI)
 

Infinity Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Infinity Pharmaceuticals Inc asset turnover ratio, the ability of Infinity Pharmaceuticals Inc 's assets to generate revenue in the second quarter 2023, increased sequentially to 0.07 in the second quarter (Jun 30 2023), yet the ratio remained below the average, as INFI's position remain challenging.

Within sector 204 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2023 compared to the preceding quarter from 3551 to 3553.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INFI Asset Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Asset Change -65.38 % -58.41 % -50.03 % -45.31 % -39.78 %
Y / Y Revenue Change -15.01 % 12.12 % 20.4 % 66.36 % 33.98 %
Asset Turnover Ratio (TTM) 0.07 0.06 0.05 0.04 0.03
INFI's Total Ranking # 3553 # 3551 # 3551 # 3110 # 0
Seq. Asset Change -28.96 % -28.84 % -18.24 % -16.24 % -14.66 %
Seq. Revenue Change -20.25 % 34.62 % -23.74 % 3.79 % 5.21 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 205
Healthcare Sector # 557
Overall Market # 3553

Asset Turnover Ratio Statistics
High Average Low
0.45 0.08 0.02
(June 30. 2016)  




INFI Company Profile • Back to INFI Efficiency Comparisons • Compare INFI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Assets at quarter ending Jun 30 2023
Durect Corp  0.33 $ 19.427  Millions$ 58.894  Millions
Aurinia Pharmaceuticals Inc   0.33 $ 160.117  Millions$ 489.954  Millions
Bausch Health Companies Inc   0.32 $ 8,350.000  Millions$ 25,733.000  Millions
Evoke Pharma Inc   0.32 $ 3.570  Millions$ 11.070  Millions
Sarepta Therapeutics Inc   0.32 $ 1,003.434  Millions$ 3,117.548  Millions
Prestige Consumer Healthcare Inc   0.32 $ 1,129.339  Millions$ 3,512.125  Millions
Telesis Bio Inc   0.32 $ 95.322  Millions$ 297.480  Millions
Amarin Corp Plcuk  0.32 $ 281.198  Millions$ 878.672  Millions
Orthopediatrics Corp  0.32 $ 137.091  Millions$ 429.735  Millions
Viatris Inc   0.32 $ 15,601.900  Millions$ 49,167.550  Millions
Sotera Health Company  0.31 $ 975.472  Millions$ 3,104.345  Millions
Comera Life Sciences Holdings Inc   0.31 $ 1.099  Millions$ 3.501  Millions
Biocorrx Inc   0.31 $ 0.237  Millions$ 0.763  Millions
Mirum Pharmaceuticals Inc   0.31 $ 115.781  Millions$ 373.593  Millions
Travere Therapeutics Inc   0.31 $ 226.054  Millions$ 735.865  Millions
Guardant Health Inc   0.31 $ 510.159  Millions$ 1,665.853  Millions
Acorda Therapeutics Inc   0.31 $ 116.914  Millions$ 382.134  Millions
Revance Therapeutics Inc   0.31 $ 186.401  Millions$ 609.707  Millions
Phenomex Inc   0.31 $ 71.798  Millions$ 234.968  Millions
23andme Holding Co  0.30 $ 295.656  Millions$ 969.796  Millions
Pulmonx Corporation  0.30 $ 60.196  Millions$ 197.566  Millions
Cartesian Therapeutics Inc   0.30 $ 48.692  Millions$ 159.838  Millions
The Cooper Companies Inc   0.30 $ 3,513.900  Millions$ 11,572.550  Millions
Neurometrix Inc   0.30 $ 7.196  Millions$ 23.771  Millions
Glaukos Corp  0.30 $ 296.794  Millions$ 985.046  Millions
Rvl Pharmaceuticals Plc  0.30 $ 35.973  Millions$ 120.094  Millions
Clever Leaves Holdings Inc   0.30 $ 16.623  Millions$ 55.645  Millions
Theralink Technologies Inc   0.30 $ 0.733  Millions$ 2.455  Millions
Revvity Inc  0.30 $ 4,225.987  Millions$ 14,270.122  Millions
Beone Medicines Ltd   0.29 $ 1,810.785  Millions$ 6,197.704  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.